PainReform Shares Are Trading Lower. The Company Announced an Update Regarding Its Phase 3 Clinical Trial Evaluating PRF-110 in Post-surgical Pain Management of Patients Undergoing Bunionectomy.
PainReform Shares Are Trading Lower. The Company Announced an Update Regarding Its Phase 3 Clinical Trial Evaluating PRF-110 in Post-surgical Pain Management of Patients Undergoing Bunionectomy.
PainReform股票交易下跌。該公司宣佈了關於其針對接受蹠骨切除術患者術後疼痛管理的PRF-110三期臨牀試驗的最新進展。
PainReform Shares Are Trading Lower. The Company Announced an Update Regarding Its Phase 3 Clinical Trial Evaluating PRF-110 in Post-surgical Pain Management of Patients Undergoing Bunionectomy.
PainReform股票交易下跌。該公司宣佈了關於其針對接受蹠骨切除術患者術後疼痛管理的PRF-110三期臨牀試驗的最新進展。